Our CapnoVue(R) family of face masks provide reliable and consistent sampling of exhaled CO2 for virtually all patient positions and clinical situations. Sales are currently growing at 75% MOM with partner Salter Labs and independent sales to DOD & VA . Our goal is to be selling $10 million in 2018 and are projecting to be profitable mid-2018. With ten issued patents and FDA cleared devices, we are seeking $ for mold tooling to lower COGS.